NEW: MalariaGEN move to LSTM... more

Dr Hema Sharma

Senior Director, Global Health; GSK.

Projects

Pf3k

Partner studies

1128 A global survey of P. vivax genome variation in samples from two GSK phase 3 clinical trials of tafenoquine in Pv relapse/reinfection (trial names DETECTIVE and GATHER)

Links

ORCID

LinkedIn

Partner studies

Contact me about

1128 A global survey of P. vivax genome variation in samples from two GSK phase 3 clinical trials of tafenoquine in Pv relapse/reinfection (trial names DETECTIVE and GATHER)